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Abstract
Background: Several activities of the transmembrane form of TNF (memTNF) in immune responses to intracellular bacterial
infection have been shown to be different from those exerted by soluble TNF. Evidence is based largely on studies in
transgenic mice expressing memTNF, but precise cellular mechanisms are not well defined and the importance of TNF
receptor regulation is unknown. In addition, memTNF activities are defined for a particular modification of the extracellular
domain of TNF but a direct comparison of different mutant memTNF molecules has not been done in vivo.
Methodology: To understand the activities of memTNF we compared two commonly used mouse strains lacking soluble
TNF but possessing functional and normally regulated membrane-bound TNF knockin (memTNF KI) for their capacity to
generate cell-mediated immune responses and resistance to M. bovis BCG infection, and to regulate TNF receptors.
Principal Findings: M. bovis BCG infection resulted in similar bacterial loads in one strain of memTNF KI (memTNF
D1–9,K11E)
and in wild-type mice, in contrast, the other strain of memTNF KI mice (memTNF
D1–12) showed higher sensitivity to infection
with high mortality (75%), greater bacterial load and massive lung pathology. The pattern of cytokines/chemokines,
inflammatory cells, pulmonary NF-kB phosphorylation, antigen-dependent IFN-c response, and splenic iNOS was impaired
in M. bovis BCG-infected memTNF
D1–12 KI mice. Macrophages expressing TNFR2 were reduced but soluble TNFRs were
higher in memTNF
D1–12 KI mice during the infection. In vitro, M. bovis BCG-induced NF-kB activation and cytokines were also
decreased in memTNF
D1–12 KI bone marrow-derived macrophages.
Conclusion: Our data show that two memTNF molecules exerted very different activities upon M. bovis BCG infection
resulting in protection or not to bacterial infection. These results suggest a regulatory mechanism of memTNF and TNF
receptors being critical in the outcome of the infection and highlight the role of cell-bound and soluble TNFR2 in memTNF-
mediated anti-microbial mechanisms.
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Introduction
Tumor necrosis factor (TNF) is a major pro-inflammatory
cytokine playing an important role in the pathogenesis of chronic
inflammatory diseases such as rheumatoid arthritis, Crohn’s
disease or psoriatic arthritis [1]. Most activities exerted by TNF
were originally attributed to the soluble form of TNF (solTNF), a
17-kDa soluble TNF molecule generated by cleavage of its 26-kDa
precursor, transmembrane or membrane TNF (memTNF). The
generation of uncleavable memTNF by mutations in the region
cleaved by the TACE (TNF-a converting enzyme) and subsequent
studies on cells, transgenic mice and later in memTNF knockin
(KI) mice without soluble TNF and in human cells have shown the
importance of activities mediated by the transmembrane form of
TNF [2,3]. However, it is still unclear how memTNF-mediated
effects are influenced by several factors including the nature of
mutations generated on the memTNF molecule, and regulatory
mechanisms involving TNFR and their soluble forms which have
not been explored in vivo. As an example of the reported
complexity, studies on the same memTNF expressed in mice
either as a transgene or as a knockin have resulted in opposite
effects, as a memTNF (deletion 1–12, memTNF
D1–12) was
previously shown to mediate inflammatory reactions in a
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D1–12 KI mice did not
show liver inflammation after LPS/D-GalN challenge [5]. We
have recently reported that another variant of memTNF (deletion
1–9 and substitution Lys to Glu in position 11, memTNF
D1–9,K11E)
in KI mice [6] was not pathogenic for liver inflammation but only
soluble TNF was causing hepatitis in LPS/BCG and LPS/D-
GalN-induced liver damage [7].
Host protection mechanisms mediated by transmembrane TNF
against bacterial and parasitic infections have been studied mainly
using memTNF
D1–9,K11E KI mice. It was reported that
memTNF
D1–9,K11E KI mice were protected from low-dose Listeria
monocytogenes infection but only partially or not protected from high
dose infection [8,9]. A study of L. monocytogenes infection in
memTNF
D1–12 KI mice showed partial survival of these mice to
low bacterial dose [5]. The memTNF
D1–9,K11E form was shown to
be sufficient to develop partial innate immunity to Francisella
tularensis live vaccine strain [10]. An important role of
memTNF
D1–9,K11E was observed in the resolution of the
inflammatory lesion induced by Leishmania major infection [11].
Infection with M. tuberculosis of memTNF
D1–9,K11E KI mice
showed protection against acute but not to chronic infection
[12,13]. These studies confirmed our previous results on
transgenic mice expressing a different mutant memTNF (D-12 to
210, D-2 to +1, K11E) expressed as a transgene in mice deficient
in both TNF and LTa (transgenic memTNF in TNF/LTa
2/2)
[14,15,16]. Only one study has been reported for M. tuberculosis
infection using memTNF
D1–12 KI mice showing protection to
acute but not to chronic infection, and the infection dosage were
lower than those used in the studies of memTNF
D1–9,K11E KI mice
[17] (Table 1).
Infection with M. bovis BCG in memTNF KI mice has shown
differential susceptibilities of these mice. MemTNF
D1–9,K11E KI
mice intranasally infected showed total resistance to M. bovis BCG
infection, whereas memTNF
D1–12 KI mice intravenously (i.v.)
infected were only 50% resistant [17,18]. The reasons of
differential susceptibility of the two memTNF KI mouse strains
were not addressed in previous publications. To date, a rigorous
comparison of immune responses elicited by intracellular bacterial
infection in the two memTNF KI mice has not been performed
and the importance of TNF receptors during a bacterial infection
is unknown.
To gain insights into the role of memTNF and its interaction
with TNF receptors in protection against intracellular bacterial
infection, we have compared resistance and cell-mediated
immunity to M. bovis BCG infection of memTNF
D1–9,K11E KI
and memTNF
D1–12 KI mice, and studied the pattern of cytokine
and TNF receptor expression, and NF-kB activation. We used a
systemic M. bovis BCG infection that allows these studies in highly
sensitive mice such as TNF2/2 mice in which the pattern of
inflammatory lesions have been well characterized. Considering
that M. bovis BCG is the most widely distributed vaccination with
live bacteria, deep investigation on the factors influencing
protective immunity is still required.
Our results show important differences between the two
memTNF KI mouse strains in both resistance and cell-mediated
immune responses to M. bovis BCG infection. These differences
reveal distinct activities mediated by the interaction of either
memTNF
D1–9,K11E KI or memTNF
D1–12 with TNF receptors.
Our data show that cell-bound as well as soluble TNFR2 play a
critical role in the outcome of the infection.
Results
Mice without solTNF and expressing only memTNF
D1–
9,K11E are more resistant to M. bovis BCG infection than
mice with memTNF
D1–12
To explore the protective activities of the transmembrane form
of TNF against M. bovis BCG infection, we compared the
development of host defense mechanisms against this pathogen
in two different memTNF KI mouse strains. We infected wild-
type, memTNF
D1–9,K11E [6] and memTNF
D1–12 [5], double
TNFR1/TNFR22/2, and TNF2/2 mice by the i.v. route.
Wild-type mice were resistant to M. bovis BCG infection; one out of
14 (93% survival) memTNF
D1–9,K11E KI mice died, whereas 7 out
of 10 (30% survival) memTNF
D1–12 KI mice succumbed to the
infection with loss of body weight, and all TNFR1/TNFR2 2/2
and TNF2/2 mice died (Fig. 1A, B). After infection with a
different strain of M. bovis BCG (Pasteur), we observed total
survival of memTNF
D1–9,K11E KI mice, while 80% of
memTNF
D1–12 KI mice succumbed to the infection between days
25 and 45 and exhibited significant loss of body weight (Fig. S1).
Infection of memTNF
D1–12 KI mice deficient in TNFR1 or
TNFR2 resulted in similar pattern than memTNF
D1–12 KI mice at
day 50 after infection (Fig. S1A, B). Therefore, both infections with
M. bovis BCG strains confirmed the higher susceptibility of
memTNF
D1–12 KI mice compared to memTNF
D1–9,K11E KI and
wild-type mice. The enhanced susceptibility of memTNF
D1–12 KI
mice versus memTNF
D1–9,K11E KI mice was confirmed by
Table 1. M. tuberculosis and M. bovis BCG infection studies performed in memTNF KI mice.
MemTNF KI
mouse strain Mycobacteria
Dose and route of
inoculation Survival References
MemTNF
D1–9,K11E M. tuberculosis 70–100 CFU by aerosol Succumbed:130–200 days [13]
MemTNF
D1–9,K11E M. tuberculosis 100 CFU intranasally Succumbed:110–200 days [12]
MemTNF
D1–9,K11E BCG Pasteur 10
6 CFU intranasally 100% survival at 120 days [18]
MemTNF
D1–9,K11E M. tuberculosis 50–100 CFU by aerosol Succumbed: 150–230 days [18]
MemTNF
D1–12 BCG Pasteur 2610
6 intravenously 50% survival at 90 days [17]
MemTNF
D1–12 M. tuberculosis 10–30 CFU by aerosol Succumbed: 50–170 days [17]
MemTNF
D1–9,K11E BCG Connaught 10610
6 intravenously 93% survival at 100 days Present study
MemTNF
D1–9,K11E BCG Pasteur 10610
6 intravenously 100% survival at 100 days Present study
MemTNF
D1–12 BCG Connaught 10610
6 intravenously 30% survival at 100 days Present study
MemTNF
D1–12 BCG Pasteur 106intravenously 20% survival at 100 days Present study
doi:10.1371/journal.pone.0031469.t001
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Deficiency of either TNFR1 or TNFR2 in memTNF
D1–12 KI mice
showed an increased bacterial load in liver and lungs at 4 weeks
after M. bovis BCG infection as compared to memTNF
D1–12 KI
mice, indicating that both receptors could play a role in
memTNF
D1–12 KI signalling (Fig. S1C, D). Histopathological
examination of lungs at 4 weeks post-infection revealed that
memTNF
D1–9,K11E KI mice formed granulomas of larger size than
wild-type mice (average diameter was 197687 versus 170630 mm
in wild-type) (Fig. 2A, B), and that these granulomas contained
multinucleated giant cells as in wild-type pulmonary granulomas
(Figure 2E, F). This pathology contrasted with that observed in
memTNF
D1–12 KI and TNFR1/TNFR22/2 mice which showed
extended pulmonary lesions (average diameter of inflammatory
foci was 3106100 mm and 4816120 mm, p,0,01 and p,0,02 vs
wild-type, respectively) (Fig. 2C, D) exhibiting abundant lympho-
cytes and absence of multinucleated giant cells (Fig. 2G, H). In
particular, TNFR1/TNFR22/2 mice developed extensive ne-
crotic pulmonary lesions (Fig. 2H).
Different cytokine, chemokine, inflammatory cell and NF-
kB activation during M. bovis BCG infection in
memTNF
D1–9,K11E and memTNF
D1–12 KI mice
To determine whether memTNF
D1–9,K11E KI mice and
memTNF
D1–12 KI mice are able to induce Th-1 type cytokines
as well as chemokines upon M. bovis BCG infection, the levels of
IFN-c, IL-12p40, RANTES and MCP-1 were evaluated in the
serum and lungs and compared to those of wild-type mice. IFN-c
serum levels of memTNF
D1–9,K11E KI and memTNF
D1–12 KI mice
were lower than those in wild-type mice at 2 weeks, but at 4 weeks
after M. bovis BCG infection, exacerbated expression of IFN-c was
observed only in memTNF
D1–12 KI and TNF2/2 mice, whereas
memTNF
D1–9,K11E KI mice exhibited similar level to wild-type
mice (Fig. 3A). In the lung, IFN-c amounts were similar in all
groups of mice at 2 weeks and increased in all mutant mice 4
weeks post-infection (Fig. 3B). IL-12p40 serum amounts were
comparable in memTNF
D1–9,K11E KI and wild-type mice but
lower in memTNF
D1–12 KI and TNF2/2 mice at 2 weeks, and at
4 weeks, they were higher in memTNF
D1–12 KI, and TNF2/2
mice (Fig. 3C). IL-12p40 lung content also revealed increased
values in all mutant mice at 4 weeks infection compared to wild-
type mice (Fig. 3D).
Serum amounts of RANTES at 2 weeks infection were reduced
in mutant mice, but at 4 weeks, levels were only lower in
memTNF
D1–12 KI and TNF2/2 mice compared to wild-type
mice (Fig. 3E). RANTES lung amounts were increased at 4 weeks
of infection in memTNF
D1–9,K11E KI and in memTNF
D1–12 KI
mice compared to wild-type mice (Fig. 3F). MCP-1 serum levels
were decreased in mutant mice at early infection as also observed
for lung levels in all mutant mice, but at 4 weeks infection they
were increased in memTNF
D1–12 KI and TNF2/2 mice but not
in memTNF
D1–9,K11E KI mice compared to wild-type mice,
suggesting an enhanced activity of lung macrophages (Fig. 3G, H).
A general pattern of activation of inflammatory mediators revealed
a delay in mutant mice at early infection which was attenuated in
memTNF
D1–9,K11E KI mice. At late infection in mice suffering of
progressive disease, an exacerbation of cytokine release was
observed such as in memTNF
D1–12 KI and TNF2/2 mice
whereas memTNF
D1–9,K11E KI mice exhibited normal or atten-
uated responses. To gain insight into the deficient pattern of
activation observed at two weeks infection in memTNF KI mice,
NF-kB phosphorylation patterns were analyzed by western blot.
The pulmonary protein expression of the phosphorylated form of
the p65 NF-kB subunit was compared with the unphosphorylated
form. Phosphorylated p65 NF-kB was reduced in memTNF
D1–
9,K11E KI mice but significantly much lower in memTNF
D1–12 KI
after M. bovis BCG infection indicating impaired cell activation in
memTNF
D1–12 KI mice (Fig. 4).
To explore whether the deficient pattern of cytokines in the
circulation observed in mutant mice corresponds to the ability to
mobilize and activate inflammatory cells to the site of infection,
circulating activated inflammatory cells were characterized at
early infection. Peripheral blood leucocytes after 1 week of M. bovis
BCG infection were analyzed in memTNF
D1–9,K11E KI and
memTNF
D1–12 KI mice. Blood granulocytes (Gr1
+) were lower in
memTNF
D1–12 KI mice which showed no difference before and
after M. bovis BCG infection (Fig. S2A, B). In addition, the
proportion of monocytes CD11b
+ Gr1
2 (resident macrophages)
and CD11b
+ Gr1
+ (inflammatory macrophages) were also lower in
memTNF
D1–12 KI mice (Fig. S2C, D). These data suggest that the
capacity to activate NF-kB and inflammatory cells, and to release
cytokines and chemokines at early infection is impaired in
memTNF
D1–12 KI mice and this may be critical in the progression
of the infection.
Deficient IFN-c antigen-specific production in
memTNF
D1–12 but not in memTNF
D1–9,K11E KI mice
We further analyzed the capacity of lymphocytes to respond to
antigen-specific stimulation to explore any difference between
memTNF
D1–9,K11E KI and memTNF
D1–12 KI mouse Th1 type
immune responses. IFN-c production was assessed after antigen-
specific stimulation of splenocytes from 4 weeks M. bovis BCG-
infected mice with BCG culture proteins or with living M. bovis
BCG. MemTNF
D1–9,K11E KI splenocytes released comparable
amounts of IFN-c as wild-type, whereas memTNF
D1–12 KI
splenocytes dramatically lacked IFN-c production (Fig. 5A)
indicating a deficiency in T-antigen-specific cell activation in
memTNF
D1–12 but not in memTNF
D1–9,K11E KI mice. Splenocyte
activation with live M. bovis BCG gave similar results; IFN-c
production was lower in memTNF
D1–12 KI cells (Fig. 5B). We also
assessed antigen-activated Nitrite/Nitrate as a surrogate of NO
production, which is mainly released by macrophages, and
observed that NO production was similar in memTNF
D1–9,K11E
KI and memTNF
D1–12 KI splenocytes. Amounts were much lower
than in wild-type cells after antigen activation and also after M.
bovis BCG infection, indicating the importance of soluble TNF for
iNOS activity of macrophages (Fig. 5C, D). We further asked if
IFN-c antigen-specific deficient activation of memTNF
D1–12 cells
could be attributed to differences in splenocyte populations in
infected mice. But surprisingly, we found that the number of CD4
+
T cells was 4 times higher in memTNF
D1–12 KI compared to
memTNF
D1–9,K11E KI, and wild-type mice (Fig. S3A). However,
the total number of CD11b
+ was comparable in memTNF
D1–
9,K11E KI, memTNF
D1–12 KI and wild-type mice (Fig. 6C)
suggesting that memTNF cannot replace soluble TNF in
activating splenic iNOS ex-vivo.
iNOS levels are reduced in M. bovis BCG-infected
memTNF
D1–12 KI mice compared to memTNF
D1–9,K11E KI
mice
Activation of iNOS is a bactericidal mechanism essential for M.
bovis BCG clearance and mouse survival [19]. The expression of
iNOS protein in the spleen at 4 weeks post-infection was evaluated
by western blot. MemTNF
D1–9,K11E KI, memTNF
D1–12 KI and
TNFR1/TNFR22/2 mice showed decreased iNOS protein
expression compared to wild-type mice (Fig. 6A). In agreement
with previous experiments, memTNF
D1–9,K11E KI mice had
Membrane TNF and TNFRs Protection to BCG Infection
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D1–12 KI mice, suggesting that
memTNF
D1–9,K11E activates iNOS in vivo more efficiently than
memTNF
D1–12. These observations were confirmed by the
normalization of the iNOS band with actin (Fig. 6B). These
results indicate that iNOS activation is deficient in memTNF
D1–12
KI compared to memTNF
D1–9,K11E KI mice. We asked if the
deficiency of memTNF
D1–12 KI mice was due to reduced number
of macrophages or to a differential expression of transmembrane
TNF on macrophages and assessed the total number of CD11b
+
and CD11b
+/TNF
+ cells in spleen before and after the infection
Figure 1. Survival curve, body weight and bacterial loads in lung and liver of mice infected with 10
7CFU of M. bovis BCG. (A) Long-
term survival of mice infected with living M. bovis BCG Connaught (10
7). (B) Body weight change after M. bovis BCG infection. Wild-type and
memTNF
D1–9,K11E KI, (n=14 mice per group), memTNF
D1–12 (n=10 mice), and TNF2/2 mice (n=6 per group). Data from two representative
experiments are shown. CFU were determined in lungs (C, D) and liver (E, F) at 2 and 4 weeks after infection with 10
7 CFU of M. bovis BCG. Data are
represented as individual values and horizontal bars indicate mean (n=4–6 mice per group). Asterisks indicate statistically significant differences
between wild type and indicated group (*, p,0.03).
doi:10.1371/journal.pone.0031469.g001
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similar in wild-type, memTNF
D1–9,K11E KI and memTNF
D1–12 KI
mice indicating that this was not accounting for deficient iNOS
expression. In contrast, the number of CD4
+ T cells expressing
TNF was higher in memTNF
D1–12 KI than in memTNF
D1–9,K11E
KI and wild-type mice (Fig. S3B). Indeed, the lack of iNOS
expression in memTNF
D1–12 KI mice was not due to reduced
number of neither macrophages nor CD4 T cells expressing
memTNF. These data indicate that interaction of memTNF with
both soluble and membrane TNFRs can be implicated in
protection and susceptibility to the infection.
Alteration of TNF receptors in memTNF
D1–12 KI mice
upon M. bovis BCG infection
To investigate whether regulatory mechanisms of membrane
TNF receptor as well as TNF receptor shedding could explain the
enhanced sensitivity of memTNF
D1–12 KI mice to intracellular
bacterial infection, we analysed cells expressing TNFR1 and
TNFR2 and total amounts of TNF receptors in mouse spleen
before and after the infection. FACS analyses showed that the
number of spleen macrophages expressing TNFR1 was similar in
wild-type, memTNF
D1–9,K11E KI, and memTNF
D1–12 KI mice. In
contrast, after 4 weeks of infection, TNFR2
+ macrophages were
reduced in memTNF
D1–12 KI compared to wild-type and
memTNF
D1–9,K11E KI mice indicating a decreased signalling
through TNFR2 which is considered to play an important role in
memTNF activity (Fig. 7A, B). TNFR2 is cleaved at the cell
Figure 2. Histopathology of pulmonary lesions 4 weeks after M. bovis BCG infection. Wild-type mouse lung (A, E) shows small granulomas
containing multinucleated giant cells, memTNF
D1–9,K11E KI mouse lung (B, F) shows larger granulomas compared with wild-type, also presenting
multinucleated giant cells, and memTNF
D1–12 KI (C, G) and TNFR1/TNFR22/2 (D, H) mouse lungs exhibit large lesions containing numerous
lymphocytes, neutrophils and monocytes, but lacking multinucleated giant cells. Regions of necrosis are observed in TNFR1/TNFR22/2 lungs. Figure
is representative of two experiments (n=6 per group). Magnification A–D 1006and E–H 4006.
doi:10.1371/journal.pone.0031469.g002
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that can antagonize the activity of solTNF and memTNF.
Evaluation of the total amount of TNF receptors by ELISA in
spleen homogenates revealed that TNFR1 and TNFR2 levels were
lower at 2 weeks infection in memTNF
D1–12 KI mice, but were
significantly increased at 4 weeks infection when mice showed
disease symptoms (Fig. 7C, D). It is of interest that the amounts of
TNFR1 increased 100-folds after infection in memTNF
D1–12 KI
mouse spleen whereas in memTNF
D1–9,K11E KI and wild-type
mice this increases was only 12 and 9-folds, respectively. Similarly,
M. bovis BCG-induced TNFR2 augmented in the spleen of
memTNF
D1–12 KI mice 38-folds whereas in memTNF
D1–9,K11E
KI and wild-type mice was only 13 and 10-folds, respectively.
However, the levels of spleen TNFR2 were much higher (6- to 15-
folds) than those of TNFR1 before and after infection (Fig. 7C, D).
Similarly to the spleen, circulating sTNFR2 amounts were lower
in memTNF KI mice and increased at 4 weeks infection
suggesting that spleen pattern reflects sTNFR2. The amounts of
sTNFR1 were significantly higher in memTNF
D1–12 KI mice but
those of sTNFR2 were again much higher than sTNFR1
indicating a major role in memTNF inhibition (Fig. 7E, F). These
data suggest that TNFRs and in particular TNFR2 can be released
more abundantly by activated macrophages during an infection
leading to neutralization of memTNF
D1–12 molecules which can
be critical in severe progressive infection.
Altered M. bovis BCG-induced nitric oxide, cytokine and
chemokine responses and NF-kB activation of bone
marrow-derived macrophages from memTNF
D1–12 KI
mice
To explore whether the differences observed between the two
memTNF KI mice reflect a deficiency in macrophage activity of
memTNF
D1–12 KI mice, bone marrow-derived macrophages
Figure 3. Serum and lung levels of cytokines and chemokines after M. bovis BCG infection. IFN-c levels were assessed in serum (A) and in
lungs (B) at 2 and 4 weeks after M. bovis BCG infection. Serum (C) and lung (D) amounts of IL-12p40 were measured at 2 and 4 weeks after M. bovis
BCG infection. Data are mean 6 SEM and are representative of two independent experiments (n=6–10 per group). *, p,0.03. RANTES (E, F) and MCP-
1 (G, H) amounts were measured in serum (E, G) and in lungs (F, H) at 2 and 4 weeks after M. bovis BCG infection. Data are represented as means 6
SEM from two independent experiments (n=4–6 per group). *, p,0.04.
doi:10.1371/journal.pone.0031469.g003
Figure 4. Decreased pulmonary phosphorylated p65 NF-kB in memTNF
D1–12 KI mice after 2 weeks of M. bovis BCG infection. (A)
Phosphorylated and unphosphorylated p65 NF-kB and actin protein expressions were detected in lungs by western blot 2 weeks after M. bovis BCG
infection. (B) Quantification of phosphorylated and unphosphorylated p65 NF-kB on western blot was done by Quantity OneH analysis software on
two different experiments. Results are expressed as mean 6 SEM of relative units of phosphorylated p65 NF-kB/total p65 NF-kB( n=4–5 mice/group)
(*, p,0.02).
doi:10.1371/journal.pone.0031469.g004
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IL-6 and RANTES was assessed. Production of NO was
significantly lower in memTNF
D1–12 KI than in memTNF
D1–
9,K11E KI BMDM although the latter was reduced when compared
to wild-type BMDM (Fig. 8A). M. bovis BCG-induced IL-6 and
RANTES was similar or increased in memTNF
D1–9,K11E KI and
in wild-type BMDM but lower in memTNF
D1–12 KI and TNF2/
2 BMDM (Fig. 8B, C).
To gain insight into difference in M. bovis BCG-induced cellular
activation of the two memTNF molecules, NF-kB phosphorylation
patterns were analyzed by western blot. Phosphorylated p65 NF-
kB progressively increased in wild-type BMDM up to 5 hours
after M. bovis BCG infection. In memTNF
D1–9,K11E KI BMDM,
the activation of phosphorylated p65 NF-kB was faster than in
wild-type BMDM and was already increased 2 hours after M. bovis
BCG infection to similar levels as observed in wild-type BMDM
4 hours post-infection. In contrast, in M. bovis BCG-infected
memTNF
D1–12 KI BMDM, phosphorylation of p65 NF-kB
protein was significantly reduced which confirms that
memTNF
D1–12 KI BMDM but not memTNF
D1–9,K11E KI
BMDM are deficient in NF-kB activation (Fig. 8D, E).
Discussion
The role of transmembrane TNF has been analyzed in different
systems and it is now accepted that memTNF mediates important
activities at the cellular level as well as in host defense mechanisms.
Early reports of memTNF-mediated activities described the
human memTNF
D1–12 molecule which was shown to induce cell
death and to be a predominant ligand for human TNFR2
[20,21,22]. The activities of mouse memTNF molecules used in
the present study were originally analyzed by Decoster et al. on
transfected mouse cells [23]. This study showed that deletion of
the first 9 amino acids corresponding to mature TNF still led to
production of soluble TNF, but that an additional Lys to Glu
substitution at amino acid 11 gave rise to uncleavable membrane-
bound TNF (memTNF
D1–9,K11E) with biological activities similar
to wild-type TNF. Comparison of memTNF
D1–9, K11E with the
murine mutant memTNF
D1–12 showed that the latter induced 3-
fold lower GM-CSF responses and involved cooperative effects of
TNFR1 and TNFR2 [23]. The present study explores these two
memTNF molecules expressed in mouse lacking solTNF for their
capacity to stimulate cell-mediated immune responses to intracel-
lular bacteria. Our data indicate that memTNF
D1–9,K11E KI mice
are substantially more resistant to M. bovis BCG infection than
Figure 5. Antigen-specific IFN-c and nitric oxide release from splenocytes of M. bovis BCG-infected mice. IFN-c and NO (nitric oxide)
were evaluated in culture supernatant from cells incubated with antigens derived from M. bovis BCG (A and C) or with 10
3 viable M. bovis BCG (B and
D). Values are represented as mean 6 SEM (n=3 animals per group, assayed in triplicate). * p,0.04.
doi:10.1371/journal.pone.0031469.g005
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D1–12 KI mice, as demonstrated both by lower survival
and significantly higher bacterial load, severity of pulmonary
lesions and deficient pulmonary NF-kB activation in memTNF
D1–
12 KI mice. The deficiency of memTNF
D1–12 KI mice to M. bovis
BCG was confirmed by patterns of cytokine/chemokine and
inflammatory cells that resembled TNF2/2 whereas
memTNF
D1–9,K11E KI mice were more similar to wild-type mice
or showed an intermediate phenotype that was in general sufficient
to mount an efficient immune response to M. bovis BCG infection.
These two memTNF mouse strains have been previously
infected with M. bovis BCG using two different routes and dosages.
All memTNF
D1–9,K11E KI mice survived to an intranasal infection
with 10
6 CFU and only 50% of memTNF
D1–12 KI mice survived
to an intravenous infection (2610
6 ) but infection conditions
cannot be properly compared [17,18] (see Table 1). Infection with
Figure 6. Decreased iNOS protein in memTNF KI but similar number of splenic CD11b
+/TNF
+ cells 4 weeks after M. bovis BCG
infection. (A) Spleen iNOS protein expression was detected by western blot 4 weeks after M. bovis BCG infection. (B) iNOS protein was quantified by
Image Quant software. Results are expressed as mean 6 SEM of relative units of iNOS/actin (n=4, except for TNFR1/TNFR22/2 mice n=2 per group).
*, p,0.04. FACS analyses showing the number of CD11b
+ cells (C) and of CD11b
+/TNF
+ (D) in the spleen of uninfected, 2 and 4 weeks infected mice.
Results are shown as mean 6 SEM of positive cells per spleen (n=4). *, p,0.01 compared to wild-type mice.
doi:10.1371/journal.pone.0031469.g006
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memTNF strains as 100% memTNF
D1–9,K11E KI resisted [8]
whereas only 10% memTNF
D1–12 KI mice survived to 10
4 CFU
[5]. Similarly, infection with M. tuberculosis showed different
susceptibilities since memTNF
D1–9,K11E KI mice infected with
50–100 CFU died 150–230 days whilst memTNF
D1–12 KI mice
infected with 10–30 CFU died 50–170 days after (Table 1). M.
bovis BCG-infected mice expressing memTNF
D1–12 but neither
TNFR2 nor TNFR1 showed no significant differences in survival
at day 50 compared to memTNF
D1–12 KI mice although
memTNF
D1–12 KI-TNFR22/2 started to succumb earlier. A
previous report has shown that 45 days after M. tuberculosis
infection about 20% of memTNF
D1–12 KI-TNFR22/2 died
while about 50% of memTNF
D1–12 KI-TNFR12/2 and
memTNF
D1–12 KI mice succumbed [17]. Similarly to results
shown for M. tuberculosis infection, the pattern of pulmonary
bacterial load was not significantly different in memTNF
D1–12 KI
compared to memTNF
D1–12 KI-TNFR22/2 and memTNF
D1–12
KI-TNFR12/2 mice after M. bovis BCG infection. Our
interpretation is that memTNF-TNFR2 interaction may play a
role at early infection but then, the incidence on bacterial load at 4
weeks infection is minimal as protection can be mediated by
cooperation of both TNF receptors, and in addition, other
Figure 7. Lower number of macrophages expressing membrane bound TNFR2 but higher soluble TNFRs in memTNF
D1–12 KI mice.
FACS analyses showing number of spleen CD11b
+ cells expressing membrane TNFR1 (A) or TNFR2 (B) before or during M. bovis BCG infection. Results
are shown as means 6 SEM of spleen cell numbers (n=3–4). *, p,0.02 compared to wild-type mice. Total amounts of TNFR1 (C) and TNFR2 (D) were
evaluated on total spleen extracts during M. bovis BCG infection. Results are shown as means 6 SEM of pg per spleen (n=4–6). *, p,0.05 compared
to wild-type mice. Amounts of solTNFR1 (E) and solTNFR2 (F) were assessed in the serum of mice before and after infection. Results as represented as
means 6 SEM of pg/ml of serum (n=6–10). *, p,0.05 compared to wild-type.
doi:10.1371/journal.pone.0031469.g007
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disease outcome.
To further explore other factors of interest favouring protection,
we analysed the capacity of spleen cells to respond to antigens and
to produce IFN-c and observed that memTNF
D1–12 KI were
deficient whereas memTNF
D1–9,K11E KI cells were similar to wild-
type cells. Surprisingly, the number of CD4
+ T cells was four-fold
higher in the spleen of memTNF
D1–12 KI indicating that
memTNF
D1–12 KI cells are unable to respond to antigenic
stimulation spite the moderated expansion of spleen CD4
+ T
cells. Previous report identified TNF as a negative regulator of
Th1 type immune response during intracellular bacterial infection
and showed an uncontrolled expansion of spleen CD4
+ T cells, a
marked increase of circulating and antigen-specific IFN-c in
Figure 8. BMDM nitric oxide, IL-6, RANTES production and p65 NF-kB activation by M. bovis BCG infection. NO (A), IL-6 (B) and RANTES
(C) levels were assessed in supernatant of BMDM 24 hours after M. bovis BCG infection. These results are representative of two independent
experiments and values are represented as mean 6 SEM (n=3 animals per group, assayed in triplicate) *p,0.05. (D) Phosphorylated and
unphosphorylated p65 NF-kB proteins were detected by western blot in BMDM not infected or infected with M. bovis BCG at different time points. (E)
Quantification of phosphorylated p65 NF-kB on western blot was done by Quantity OneH analysis software on two different experiments. Results are
expressed as mean 6 SEM of relative units of phosphorylated p65 NF-kB/total p65 NF-kB( n=2/group). *, p,0.05 compared to wild-type BMDM.
doi:10.1371/journal.pone.0031469.g008
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appears to restrain exacerbation of Th1 immune response caused
by lack of TNF. This is of interest considering the possibility of
using the novel class of TNF inhibitors, dominant-negative (DN)-
TNF biologics, that antagonize solTNF but not memTNF. We
have shown that DN-TNF biologics protects from hepatitis but did
not alter immunity against mycobacterial infections, presumably
by maintenance of physiological memTNF signalling [7,25].
We asked if anti-mycobacterial effector mechanisms in vivo such
as iNOS were impaired and found that iNOS was much lower in
the spleen of memTNF
D1–12 KI than in memTNF
D1–9,K11E KI
mice, confirming a decrease in bactericidal mechanisms of
memTNF
D1–12 form. To further explore the mechanisms that
can influence the activity of memTNF, we focus on the
investigation of spleen macrophages expressing TNF and TNFRs
during the infection. The number of macrophages expressing TNF
increased with the infection similarly in the three groups of mice.
Interestingly, memTNF
D1–12 KI mice showed a decrease in the
number of macrophages expressing TNFR2 suggesting that
macrophages cannot respond to M. bovis BCG-activated
memTNF
D1–12. In addition, the observation that total amount of
TNFR2 is higher in spleen homogenates from memTNF
D1–12 KI
mice indicates over-shedding of TNFR2 and that a regulatory
mechanism of memTNF inhibition may be involved in the
pathogenicity. We have previously shown that M. bovis BCG
infection induces high levels of serum TNF in parallel to the
release of TNF receptors and this is influenced by iNOS activity
since iNOS2/2 mice showed enhanced serum levels of TNF and
TNFR2 [19]. We have also reported that circulating M. bovis
BCG-induced TNF is not bioactive but rapidly neutralized by
sTNFRs during an infection [25]. The presence of high amounts
of sTNFR2 as observed in iNOS2/2 mice indicates abnormal
TACE activity in memTNF
D1–12 KI cells leading to memTNF
inactivation by sTNFR2. Although that both receptors are
enzymatically digested from cells, the amounts of sTNFR2 are
much higher (in general 5 to 15-folds) than sTNFR1 which means
that the neutralizing activity of sTNFR2 may play a predominant
role compared to sTNFR1. Several studies have pointed out the
critical role of sTNFR2 in bacterial and viral infections. A report
showed that apoptosis of M. tuberculosis-infected alveolar macro-
phages was inhibited by the release of TNFR2 that inactivated
TNF [26]. It has been shown that the immunopathology
associated with T-cell-mediated influenza clearance was abrogated
in TNFR22/2 mice and that TNFR2 was not need for
memTNF to activate MCP-1 activation, whereas both receptors
were required for MCP-1 expression by solTNF in alveolar
epithelial cells showing the complexity of sol/memTNF-mediated
activities with receptors in different systems [27].
SolTNF can mediate optimal protection against mycobacterial
infections by providing exocrine and paracrine signalling to many
cell types. In contrast, the signal of transmembrane TNF is
restricted to cell-to-cell contact which limits the intensity of the
activity. Our study shows that both memTNF molecules mediate
protection but the effect of memTNF
D1–9,K11E appears clearly
higher than the memTNF
D1–12 molecule. The fact that
memTNF
D1–9,K11E KI mice can eventually become sensitive and
succumb to the infection highlights a complex regulation of factors
mediating innate and adaptive immune responses that can be
subjected to individual situations. Among these factors the
equilibrium between memTNF and cell-bound and sTNFRs can
play a critical role in host defense against intracellular bacteria in
vivo. Our hypothesis is that the activities of memTNF can be
modulated by the levels of membrane and soluble TNF receptors
which may influence the outcome of the infection thus explaining
why memTNF KI mice can be protected or can die from the
infection. We have previously shown, using transgenic mice
expressing human soluble TNFR1-IgG, that expression levels of
the TNF neutralizing transgene determined the enhanced
protection to M. bovis BCG infection or the higher susceptibility
of mice compared to littermate control mice. We found that low
levels of soluble receptors were activating TNF expression and
macrophage effector mechanisms whilst high levels of soluble
receptors were neutralizing both sol and memTNF blocking all
protective TNF-mediated activities [16]. The immune cellular
activation was attributed to reverse signaling of memTNF binding
to solTNFRs. We hypothesize that a precise regulation of
memTNF activity can be orchestrated by membrane and soluble
TNFRs and an unbalance of this regulatory and complex system
can modify the outcome of the disease.
We finally investigate if memTNF bone-marrow derived
macrophages could show different responses upon M. bovis BCG
infection in vitro and observed that macrophages from
memTNF
D1–12 KI mice produced lower amounts of cytokines/
chemokines and showed an impaired p65 NF-kB phosphorylation
pattern indicating that the deficiency is already on memTNF
D1–12
KI macrophages which will influence the host immune response.
These data suggest that the small difference of the two memTNF
molecules results in major effects in signalling and memTNF-
mediated activities.
The mechanisms explaining the differences between memTNF
molecules with only a minor change of 3 amino acids at positions
10–12 are still not elucidated. Some hypothesis can be envisaged
to understand why such important consequence can occur in vivo.
We hypothesize that TACE can still bind to memTNF
D1–9,K11E
although unable to digest whereas the deletion of 3 amino acids
prevent the binding of TACE to memTNF
D1–12. Upon TNF
activation, TACE activity is directed to TNFR2 which can be
found decreased on macrophages but substantially increased as
solTNFR2 form that will neutralize memTNF thus preventing its
biological activities (Figure 9).
Materials and Methods
Mice
C57BL/6 mice, memTNF
D1–9,K11E KI mice [6], memTNF
D1–
12 KI mice [5] memTNF
D1–126TNFR12/2 mice, memTNF
D1–
126TNFR22/2 mice, TNFR16TNFR22/2 mice and TNF2/
2 [28] mice were maintained under conventional conditions in
the animal facility of the Medical Faculty, University of Geneva.
All animal experiments were carried out in accordance with
institutional guidelines and were approved by the academic ethical
committee on animal experimentation and the Cantonal Veter-
inary Office from Geneva, authorization number: 31.1.1005/
3202/2.
M. bovis BCG infection
Mice were infected intravenously (i.v.) with 10
7 living M. bovis
BCG Connaught [29], or BCG Pasteur GFP [30] (used for
survival curve in figure S1). Body weights were monitored during
infection, and mice were sacrificed at 2 and 4 weeks post-infection,
or 24 weeks post-infection for survival monitoring.
Determination of colony forming units (CFU) from
infected organs
The number of viable bacteria recovered from frozen organs
was evaluated as previously described [19].
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Histological analyses of liver were performed at 4 weeks after
BCG infection. Livers were fixed in 4% buffered formaldehyde
and embedded in paraffin for subsequent hematoxylin/eosin
(H&E) staining. Evaluation of the lesions was done with
Metamorph sofware.
Evaluation of serum, organ and cell culture supernatant
levels of cytokines and chemokines
For cytokine and chemokine detection, organs were homoge-
nized in 0.04% Tween 80/saline buffer (125 mg of tissue/mL) as
previously described [31]. IFN-c, IL-12p40, IL-6, MCP-1
RANTES, sTNFR1 and sTNFR2 amounts were evaluated in
serum, organ extracts or cellular supernatant by ELISA with a
sensitivity of 5–2000 pg/ml.
Western blot analysis
Splenic proteins were prepared and western blot performed as
previously described [32]. Primary antibody was a polyclonal
rabbit anti-mouse iNOS (Calbiochem, San Diego, CA; 1:2000
dilution). A rabbit polyclonal anti-actin was used as control
antibody. Goat anti-rabbit HRP was the secondary antibody (Bio-
Rad, Hercules, CA; 1:5000 dilution). Western blot was also used to
measure expression of the phosphorylated form of NF-kB in lungs
and bone marrow derived macrophages, which were lysed in
RIPA buffer complete with phosphatase (phosSTOP, Roche,
Germany) and protease inhibitors (Complete mini, Roche,
Germany). Primary antibody was either a rabbit polyclonal anti-
NF-kB p65 antibody (Santa Cruz Biotechnology, USA; 1:500
dilution) or a rabbit monoclonal anti-phosphorylated NF-kB p65
antibody (Cell Signaling Technology, USA; 1:1000 dilution). Goat
anti-rabbit HRP was used as secondary antibody (Bio-Rad, USA;
1:5000 dilution). Blots were developed with Immobilon western
chemiluminescent HRP substrate kit (Millipore, USA). The
density of bands was quantified by using Image Quant 3.3
measurement software (Molecular Dynamics, USA) or by Quan-
tity OneH analysis software (Bio-Rad, USA).
Antigen-specific release of nitric oxide and cytokines
from spleen cells
Mice were infected and sacrificed 4 weeks later, and spleen cells
were prepared as previously described [15]. Briefly, spleen cells
were treated for 5 min with a 0.155 M ammonium chloride/
0.010 M potassium bicarbonate solution for erythrocyte lysis,
washed and resuspended in DMEM+10% FCS. Cells were plated
at 5610
5 cells per well in 96-well plates and were stimulated with
either medium alone, living M. bovis BCG (10
3 CFU/well), or M.
bovis BCG culture protein extracts (17 mg/ml) for one or three
days. Cell culture medium was harvested for NO and cytokine
determination. Nitrite accumulation was evaluated in culture
medium as an indicator of NO production by Griess reagent (1%
sulfanilamide and 0.1% naphtylethylenediamide in 2.5% phos-
Figure 9. Hypothesis explaining differences between memTNF molecules. This figure presents the three situations explored in this work:
wild-type TNF molecules which are digested by the TACE, and the two memTNF forms which cannot be digested and exert their activities by cell-to-
cell contact. The difference between memTNF
D1–9,K11E and memTNF
D1–12 molecules may reside in the possibility of the TACE to bind but not cleave
the memTNF
D1–9,K11E, but in memTNF
D1–12 the TACE binding site is not accessible and the protease activity is exerted on TNFR2 which became more
frequently soluble thus neutralising memTNF
D1–12 activities.
doi:10.1371/journal.pone.0031469.g009
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concentrations were determined by comparison with OD of the
NaNO2 standards. Cytokines were determined in cell superna-
tants as described below.
Flow cytometry analyses
Flow cytometry was performed on peripheral blood leukocytes
and splenocytes. To obtain peripheral blood leukocytes, mice were
bled one week after BCG infection, and flow cytometry was
performed as previously described [33]. Spleen cells were obtained
from uninfected and at 2 and 4 weeks after M. bovis BCG infection.
Flow cytometry was performed using three- or four-color staining
and analyzed with a FACSCalibur (BD Biosciences, Mountain
View, CA). The following antibodies were used: anti-Gr1 (RB6-
8C5) (eBioscience), anti-CD11b (clone M1/70) (BD Biosciences),
anti-CD4 (clone GK1.5) (ImmunoTools GmbH, Germany),
polyclonal anti-TNF, polyclonal anti-TNFR1 and polyclonal
anti-TNFR2 (Hycult biotech). Staining was performed in the
presence of a saturating concentration of 2.4G2 anti-Fcc RII/III
mAb. For spleen, data were calculated in total number of positive
cells.
Bone marrow-derived macrophage (BMDM) culture and
treatment
Macrophages were derived from bone marrow cells as
previously described [34]. Briefly, bone marrow cells were flushed
aseptically from the femurs of mice and cultured in DMEM
supplemented with 10% fetal calf serum and 20% L929 cell-
conditioned medium [34]. After 6 days of culture, BMDM were
infected with M. bovis BCG (60 000 CFU/well) during 2, 4, 5 or
24 hours. The supernatant was harvested for NO and cytokine
determination.
Statistical analyses
The one-way ANOVA was used for all analyses. P values,0.05
were considered as statistically significant.
Supporting Information
Figure S1 Survival curve and body weight of M. bovis
BCG infected mice. (A) Long-term survival of mice infected
with living M. bovis BCG Pasteur (10
7). (B) Body weight change
after M. bovis BCG infection (n=4–5 mice per group). Data from
one representative experiment are shown. (C and D) CFU at 4
weeks after infection with 10
7 CFU of M. bovis BCG Connaught
were determined in lungs (C) and liver (D). Data are represented as
individual values and horizontal bars indicate mean (n=4–6 mice
per group). Asterisks indicate statistically significant differences
between wild type and indicated group (*, p,0.03).
(TIF)
Figure S2 Peripheral blood mononuclear cells (PBMC)
were reduced in memTNF
D1–12 KI after 1 week of M.
bovis BCG infection. (A) PBMC before infection and 1 week
after M. bovis BCG infection were stained with anti-Gr1
monoclonal antibody (mAb). PBMC were gated for cells with
higher granularity (high side–scatter properties) to distinguish
polymorphonuclear cells. Numbers indicate the mean percentages
of Gr1
+ polymorphonuclear cells. (B) Percentages of Gr1
+ cells are
shown (n=3 mice per group) (*, p,0.04). (C) PBMC from the
same group of mice before and 1 week after M. bovis BCG
infection were stained with a combination of anti-CD11b and anti-
Gr1 monoclonal antibodies (mAb) and were gated for cells with
lower granularity (low side–scatter properties) to distinguish them
from polymorphonuclear cells. (D) Percentage of cells is shown in
histogram (n=3 mice per group) (*, p,0.03).
(TIF)
Figure S3 Decreased number of splenic CD4
+ and
CD4
+/TNF
+ cells 4 weeks after M. bovis BCG infection.
Number of CD4
+ T (A) and CD4
+/TNF
+ T (B) cells in spleen at 4
weeks of M. bovis BCG infection were increased in memTNF
D1–12
KI mice. Data were represented as means 6 SEM of positive cell
number per spleen (n=3–4 mice per group) (*, p,0.02).
(TIF)
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